LongeVC
Washington D.C.longevc.com
Overview
LongeVC is a venture capital firm that invests in early-stage biotechnology and longevity-focused companies, supporting founders in therapeutics, diagnostics, and longevity infrastructure.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Unnatural Products | Mar 2026 | Series B | Co-investor |
| Red Queen Bio | Nov 2025 | Seed | Co-investor |
| Valink Therapeutics | Oct 2025 | Seed | Co-investor |
| Trogenix | Oct 2025 | Series A | Co-investor |
| Constructive Bio | Mar 2025 | Series A Extension | Co-investor |
Key People
Sergey Jakimov
Managing Partner
Garri Zmudze
General Partner
Andrei Tereshchenko
Venture Partner
Artem A. Trotsyuk
Venture Partner
Julie Liu
Venture Partner
Matt Toner
Venture Partner
Pascal Schümperli
Venture Partner
Timothy E. Morris
Venture Partner
Vlad Cernouţan
Principal
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
